Rising Threat of Antibiotic Resistance in Indian Hospitals

A recent extensive study conducted across 20 tertiary-care hospitals in India has unveiled a critical public health issue: the rise of antimicrobial resistance (AMR). This research, which involved over 150,000 patients, highlights the growing challenge posed by infections resistant to carbapenem antibiotics, a key treatment option for severe bacterial infections. The findings indicate that AMR is not only complicating treatment but also leading to increased mortality rates and soaring healthcare costs.

The study, led by Dr. Kamini Walia and published in The Lancet Regional Health, analyzed data from April 2022 to April 2025. Researchers focused on four major Gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. These pathogens are known to cause severe infections, particularly in hospitalized patients. Alarmingly, more than 60% of the Gram-negative infections examined were resistant to carbapenem antibiotics, which are crucial for treating such infections.

Mortality rates associated with carbapenem-resistant infections were significantly higher compared to those with susceptible strains. For instance, the study reported a mortality rate of 24.4% for carbapenem-resistant E. coli, compared to 17.3% for susceptible strains. Similarly, patients with carbapenem-resistant Pseudomonas aeruginosa faced a 43% higher risk of death. The financial implications are equally concerning, as the treatment for resistant infections often incurs costs 1.1 to 2 times higher than for susceptible infections, leading to longer hospital stays and increased healthcare expenditures.

The implications of these findings extend beyond individual patient outcomes to the broader healthcare system in India. The study underscores the urgent need for integrated surveillance systems that link AMR data with patient outcomes. Enhanced infection prevention strategies, timely diagnostics, and effective antimicrobial stewardship are essential to combat this escalating threat. The researchers advocate for a comprehensive approach to address AMR, emphasizing that preventing infections in healthcare settings is as crucial as developing new antibiotics.

Looking ahead, the study calls for ongoing research and policy initiatives to strengthen AMR surveillance and infection control measures. As the healthcare landscape continues to evolve, addressing the challenges posed by antimicrobial resistance will be vital for safeguarding public health in India and beyond.